3,4-dihydro-2(1h)-quinolinone has been researched along with sb 203580 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Domeyer, DM; Hauser, DR; Kammerer, B; Laufer, SA; Scior, T | 1 |
| Barlow, DJ; Ehrman, TM; Hylands, PJ | 1 |
2 other study(ies) available for 3,4-dihydro-2(1h)-quinolinone and sb 203580
| Article | Year |
|---|---|
Synthesis, biological testing, and binding mode prediction of 6,9-diarylpurin-8-ones as p38 MAP kinase inhibitors.
Topics: Adenosine Triphosphate; Binding Sites; Drug Design; Hydrophobic and Hydrophilic Interactions; p38 Mitogen-Activated Protein Kinases; Protein Binding; Purinones; Structure-Activity Relationship; Thermodynamics | 2007 |
In silico search for multi-target anti-inflammatories in Chinese herbs and formulas.
Topics: Anti-Inflammatory Agents; Crystallography, X-Ray; Cyclooxygenase 1; Cyclooxygenase 2; Databases, Factual; Drug Design; Drugs, Chinese Herbal; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Medicine, Chinese Traditional; Models, Chemical; Models, Molecular; Molecular Conformation; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase 4 Inhibitors; Structure-Activity Relationship | 2010 |